Didronel PMO a combination of the drug etidronate and calcium is licensed specifically for the treatment of established vertebral osteoporosis, or serious bone thinning of the spine.
Didronel PMO (etidronate) is specifically licensed to treat Paget’s disease, a serious bone-thinning condition. But so enthusiastic was the manufacturer about the benefits of its drug that it urged doctors to prescribe it
If you suffer from osteoporosis, new research shows that a combination of calcium, vitamin D and vitamin K - together with minerals like strontium and magnesium - may offer an alternative to pharmaceuticals, without side-effects.